Furet JP, Kong LC, Tap J, Poitou C, Basdevant A, Bouillot JL, et al
A peptide prescribed by a licensed provider and filled by a licensed pharmacy is legitimate care
A Potent And Specific CD38 inhibitor ameliorates age-related metabolic dysfunction by reversing tissue NAD+ decline
doi: 10.3390/antiox9100914
Supplements arent as well-regulated as prescription medications are by the U.S
E N D Presentation Transcript GI BLEEDING Brad Martin, MD c/o Jason De Roulet, MD July 18, 2012 OBJECTIVES Define some common terms associated with GI bleeds Review the ways patients commonly present with GI bleeds Review how to assess patients presenting with GI bleed Identify the most common causes of both upper and lower GI bleeds Identify key information to have available when calling a GI consult Review the medical and endoscopic treatments for both upper and lower GI bleeds DEFINITIONS Acute GI bleed 20:1 Coags goal INR 60 Multiple comorbidities Coagulopathy (i.e